Abiopharma

🔍 Gatoff Steven (Executive)

Company: INSEEGO CORP. (INSG)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 8,506 shares of Common Stock at $14.14 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 228,369.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,980 shares of Common Stock at $14.14 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 226,389.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to the vesting of shares from a restricted stock unit (RSU) award that was granted on 7/30/2024. The grant of the RSU was previously reported in Table I of reporting person's Form 4 filed on 8/1/2024. The vesting schedule for the award was subsequently modified from an initial structure of monthly vesting over four years (with one-fourth vesting on the first anniversary of the grant date and 1/48th vesting monthly thereafter) to a quarterly vesting schedule, including a 7.5% acceleration of vesting.
• F2: Represents shares withheld to cover payment of the tax liabilities of the reporting person related to the vesting of shares from a restricted stock unit (RSU) award that was granted on 12/24/2025. The grant of the RSU was previously reported in Table I of reporting person's Form 4 filed on 12/29/2025.The vesting schedule for the award was subsequently modified from an initial structure of monthly vesting over four years (with one-fourth vesting on the first anniversary of the grant date and 1/48th vesting monthly thereafter) to a quarterly vesting schedule, including a 7.5% acceleration of vesting.